Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DARLING INGREDIENTS INC.DAR · Entity 3512 | Director | May 07, 2026 | May 08, 2026 |
| HAIN CELESTIAL GROUP INCHAIN · Entity 7055 | Director | October 30, 2025 | November 03, 2025 |
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | Director | August 04, 2026 | August 05, 2026 |
| WELLS FARGO & COMPANY/MNWFC · Entity 2824 | Director | April 01, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DARLING INGREDIENTS INC.
Report date May 07, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,567 |
Ending reported balance
After 2026-05-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-07 · Grant · Acquired 2,650 · Balance 20,437 Row 2 · 2026-05-07 · Grant · Acquired 130 · Balance 20,567 F1: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026. F2: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Stock Units (DSUs) granted in accordance with the 2026 Omnibus Incentive Plan. The number of shares of the issuer's common stock underlying the DSU award is equal to the amount of the prorated annual cash compensation increase the reporting person elected to receive in DSUs, divided by the closing market price of a share of the issuer's common stock on January 2, 2026.
F2: These DSUs vest in full on December 31, 2026, provided however that if the reporting person ceases to serve as a director on the Issuer's board prior to that date, these DSUs will vest in a prorated portion based on the reporting person's time of service and the unvested DSUs will be forfeited.
HAIN CELESTIAL GROUP INC
Report date October 30, 2025 · Filed November 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 202,721 |
Reported balance
After 2025-10-30 transaction · row 1
1 source rowRow 1 · 2025-10-30 · Grant · Acquired 114,729 · Balance 202,721 F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | IndirectBy Clesteen A. Clark Trust | 83,000 |
Reported balance
Holding disclosure · report date 2025-10-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 83,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted share units ("RSUs") as compensation under the Issuer's compensation program for non-employee directors. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of October 30, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Prestige Consumer Healthcare Inc.
Report date August 04, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 16,511 |
Reported balance
After 2026-08-04 transaction · row 1
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 2,981 · Balance 16,511 F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.
WELLS FARGO & COMPANY/MN
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 39,589.3131 |
Reported balance
After 2026-04-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-01 · Grant · Acquired 341.3181 · Balance 39,589.3131 F1: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock. F2: Deferred compensation shares payable in a lump sum or installments based upon director's election. F3: Includes dividend equivalents reinvested in additional Phantom Stock Units. |
| Common Stock, $1 2/3 Par ValueSEC Table I · non-derivative | Direct | 4,022 |
Reported balance
Holding disclosure · report date 2026-04-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,022 |
Filing footnotes · ownership attribution and instrument terms
F1: Each Phantom Stock Unit represents the right to receive one share of Wells Fargo & Company common stock.
F2: Deferred compensation shares payable in a lump sum or installments based upon director's election.
F3: Includes dividend equivalents reinvested in additional Phantom Stock Units.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AdvancePierre Foods Holdings, Inc.
Report date June 06, 2017 · Filed June 07, 2017
Section 16 reporting ended · disclosed 2017-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2017-06-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2017-06-06 · Other · Disposed 8,211 · Balance 22,726 Row 2 · 2017-06-07 · Disposition to issuer · Disposed 22,726 · Balance 0 F1: Upon the closing of the merger (the "Merger") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc. (the "Issuer"), Tyson Foods, Inc. and DVB Merger Sub, Inc., each outstanding share of Issuer common stock ("Common Stock") was cancelled and converted into the right to receive a cash payment of $40.25 per share (the "Merger Consideration"), and each outstanding Issuer restricted stock unit was converted into the right to receive an amount of cash equal to the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon the closing of the merger (the "Merger") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc. (the "Issuer"), Tyson Foods, Inc. and DVB Merger Sub, Inc., each outstanding share of Issuer common stock ("Common Stock") was cancelled and converted into the right to receive a cash payment of $40.25 per share (the "Merger Consideration"), and each outstanding Issuer restricted stock unit was converted into the right to receive an amount of cash equal to the Merger Consideration.
Mead Johnson Nutrition Co
Report date June 15, 2017 · Filed June 15, 2017
Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 1
1 source rowRow 1 · 2017-06-15 · Disposition to issuer · Disposed 12,661 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-06-15 · Disposition to issuer · Disposed 1,709 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.
F3: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.
OMEGA PROTEIN CORP
Report date December 19, 2017 · Filed December 21, 2017
Section 16 reporting ended · disclosed 2017-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-19 transaction · row 1
1 source rowRow 1 · 2017-12-19 · Disposition to issuer · Disposed 3,374 · Balance 0 F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 3,374 shares of which vested immediately prior to the effective time of the Merger (as defined below). F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 3,374 shares of which vested immediately prior to the effective time of the Merger (as defined below).
F2: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2019 Filed Nov 21, 2019 21:41 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 9,354 | $0.00 | $0.00 |
DisclosureSEC source: 0000910406-19-000124 · wf-form4_157437246369292.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,071 F1 · shares: Represents a restricted stock award received as compensation under the Issuer's compensation program for non-employee directors. The award will vest on the earlier of November 19, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 17:13 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 667.5499 | $49.06 | $32,750.00 |
DisclosureSEC source: 0001127602-19-029913 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,291.0485 Underlying: Common Stock, $1 2/3 Par Value · 667.5499 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 17:01 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 686.7268 | $47.69 | $32,750.00 |
DisclosureSEC source: 0001127602-19-023873 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,551.7487 Underlying: Common Stock, $1 2/3 Par Value · 686.7268 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 17:22 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 3,802 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016165 · form4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,022 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 17:29 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 729.8709 | $48.81 | $35,625.00 |
DisclosureSEC source: 0001127602-19-014427 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,806.1362 Underlying: Common Stock, $1 2/3 Par Value · 729.8709 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| January 07, 2019 Filed Jan 9, 2019 21:40 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 13,360 | $17.44 | $232,998.40 |
DisclosureSEC source: 0000910406-19-000005 · wf-form4_154706999101738.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,717 F1 · shares: Represents a grant of restricted shares of the Issuer's common stock, which will vest on October 29, 2019. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 18:05 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 203.4505 | $46.08 | $9,375.00 |
DisclosureSEC source: 0001127602-19-000535 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031.0133 Underlying: Common Stock, $1 2/3 Par Value · 203.4505 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 17:04 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 179.4258 | $52.25 | $9,375.00 |
DisclosureSEC source: 0001127602-18-029293 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,789.62 Underlying: Common Stock, $1 2/3 Par Value · 179.4258 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| July 01, 2018 Filed Jul 3, 2018 17:27 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 169.1017 | $55.44 | $9,375.00 |
DisclosureSEC source: 0001127602-18-022489 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,576.5432 Underlying: Common Stock, $1 2/3 Par Value · 169.1017 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 15:38 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 3,257 | $52.51 | $171,025.07 |
DisclosureSEC source: 0001127602-18-015284 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,376.2341 Underlying: Common Stock, $1 2/3 Par Value · 3,257 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 15:38 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015284 · form4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220 Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 23:56 UTC | HAIN CELESTIAL GROUP INC HAIN · Entity 7055 | GrantCommon Stock | 7,357 | $30.99 | $227,993.43 |
DisclosureSEC source: 0000910406-18-000025 · wf-form4_152288615486177.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,357 F1 · shares: Represents a grant of restricted shares of the Issuer's common stock, which will vest in three (3) equal installments on April 2, 2019, 2020 and 2021. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 17:54 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 178.8781 | $52.41 | $9,375.00 |
DisclosureSEC source: 0001127602-18-013566 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119.2341 Underlying: Common Stock, $1 2/3 Par Value · 178.8781 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:12 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantPhantom Stock Units · Derivative | 934 | $61.09 | $57,058.06 |
DisclosureSEC source: 0001127602-18-001093 · form4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 934 Underlying: Common Stock, $1 2/3 Par Value · 934 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom stock unit represents the right to receive one share of Wells Fargo & Company common stock. F2 · derivative.exercise_date: Deferred compensation shares payable in installments based upon director's election. F2 · derivative.expiration_date: Deferred compensation shares payable in installments based upon director's election. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:12 UTC | WELLS FARGO & COMPANY/MN WFC · Entity 2824 | GrantCommon Stock, $1 2/3 Par Value | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-001093 · form4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49 Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 18:30 UTC | OMEGA PROTEIN CORP OME · Entity 170819 | Disposition to issuerCommon Stock | 3,374 | $22.00 | $74,228.00 |
DisclosureSEC source: 0000899243-17-029432 · doc4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Includes shares of common stock (the "Common Stock") of Omega Protein Corporation (the "Company") held by the Reporting Person and awards of shares of restricted Common Stock previously granted, 3,374 shares of which vested immediately prior to the effective time of the Merger (as defined below). F2 · price: On December 19, 2017, pursuant to the Agreement and Plan of Merger dated as of October 5, 2017 (the "Merger Agreement"), by and among the Company, Cooke Inc. ("Cooke") and Alpha MergerSub, Inc. ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger") with the Company continuing as the surviving entity and a wholly-owned indirect subsidiary of Cooke. Pursuant to the Merger Agreement, each share of Common Stock of the Company issued and outstanding immediately prior to the effective time of the merger was automatically cancelled and converted into the right to the receive $22.00 in cash, less any required tax withholdings. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:43 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 1,709 | $90.00 | $153,810.00 |
DisclosureSEC source: 0001104659-17-039509 · a4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,709 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3 · price: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.exercise_date: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.expiration_date: This RSU was originally scheduled to vest on February 28, 2018. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:43 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerCommon Stock | 12,661 | $90.00 | $1,139,490.00 |
DisclosureSEC source: 0001104659-17-039509 · a4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc, and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share. Read SEC document |
| June 07, 2017 Filed Jun 7, 2017 18:06 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | Disposition to issuerCommon Stock | 22,726 | $40.25 | $914,721.50 |
DisclosureSEC source: 0001209191-17-038405 · doc4.xml · nonDerivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Upon the closing of the merger (the "Merger") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of April 25, 2017, by and among AdvancePierre Foods Holdings, Inc. (the "Issuer"), Tyson Foods, Inc. and DVB Merger Sub, Inc., each outstanding share of Issuer common stock ("Common Stock") was cancelled and converted into the right to receive a cash payment of $40.25 per share (the "Merger Consideration"), and each outstanding Issuer restricted stock unit was converted into the right to receive an amount of cash equal to the Merger Consideration. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 18:06 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | OtherCommon Stock | 8,211 | $40.25 | $330,492.75 |
DisclosureSEC source: 0001209191-17-038405 · doc4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,726 Read SEC document |
| May 23, 2017 Filed May 25, 2017 16:16 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | GrantCommon Stock | 2,984 | $40.22 | $120,016.48 |
DisclosureSEC source: 0001209191-17-035335 · doc4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,937 F1 · security: Annual grant of AdvancePierre Foods Holdings, Inc. (the "Company") restricted stock units made pursuant to the Company's Independent Director Compensation Policy (filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended October 1, 2016, filed with the SEC on October 9, 2016) made in connection with the election or reelection of such director at the Company's 2017 annual meeting of stockholders. F2 · security: Award of restricted stock units under the AdvancePierre Foods Holdings, Inc. 2009 Omnibus Equity Incentive Plan, which vest 1/3 per year over 3 years. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 16:34 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | GrantCommon Stock | 751 | $30.31 | $22,762.81 |
DisclosureSEC source: 0001209191-17-020535 · doc4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,953 F1 · security: Represents non-employee director compensation, paid in arrears in shares of Common Stock with a fair market value of $22,750, value based on the closing price of the Common Stock on March 13, 2017. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 10:11 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 2,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016255 · doc4.xml · derivative · entry 3 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,373 shares Expires 2017-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F2 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 10:11 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Exercise / conversionCommon Stock | 2,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016255 · doc4.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 10:11 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantRestricted Stock Unit (RSU) · Derivative | 1,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016255 · doc4.xml · derivative · entry 2 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,709 Underlying: Common Stock · 1,709 shares Expires 2018-02-28 F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. F2 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. Read SEC document |
| October 14, 2016 Filed Oct 14, 2016 14:55 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | GrantCommon Stock | 1,631 | $27.91 | $45,521.21 |
DisclosureSEC source: 0001179110-16-030710 · edgar.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,202 F1 · security: Represents non-employee director compensation, paid in arrears in shares of Common Stock with a fair market value of $45,500, valued based on the closing price of the Common Stock on October 13, 2016. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 15:11 UTC | AdvancePierre Foods Holdings, Inc. APFH · Entity 175379 | GrantCommon Stock | 897 | $25.39 | $22,774.83 |
DisclosureSEC source: 0001179110-16-029667 · edgar.xml · nonDerivative · entry 1 Clark Celeste A. · CIK 0001261319 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,571 F1 · security: Represents non-employee director compensation, paid in arrears in shares of Common Stock with a fair market value of $22,750, valued based on the closing price of the Common Stock on September 13, 2016, the day immediately following the date by which each non-employee director was required to elect to receive Common Stock of the Company in lieu of a cash retainer for the applicable period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.